5E Advanced Materials (FEAM) Stock

Company unveils strategic decision to progress forward with calcium chloride as optimal by-product to reduce CAPEX, reports positive operational progress on its small-scale facility production and plant operations, commercial developments, and capital funding Company unveils strategic decision to progress forward with calcium chloride as optimal by-product to reduce CAPEX, reports positive operational progress on its small-scale facility production and plant operations, commercial developments, and capital funding

New senior leadership appointment will be responsible for leading 5E's commercial strategy, securing offtake agreements, and advancing customer engagement and partnerships New senior leadership appointment will be responsible for leading 5E's commercial strategy, securing offtake agreements, and advancing customer engagement and partnerships

5E Advanced Materials, Inc. (NASDAQ:FEAM ) Q4 2024 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Nathan Skown - IR Paul Weibel - CEO J.T. Starzecki - CSO Joseph Caminiti - IR Conference Call Participants Canyon Hayes - D.A.

Company to host call this evening to provide updates on small-scale facility production and operations, as well as capital and commercial strategy Company to host call this evening to provide updates on small-scale facility production and operations, as well as capital and commercial strategy

HESPERIA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,333,333 shares of common stock in a registered direct offering at a price of $0.75 per share, along with Series A warrants to purchase up to an aggregate of 5,333,333 shares of common stock and Series B warrants to purchase up to an aggregate of 5,333,333 shares of common stock in a concurrent private placement. Each of the Series A warrants and Series B warrants will have an exercise price of $0.7981 and will be exercisable six months from the date of issuance. The Series A warrants will expire on the five and one half-year anniversary from the date of issuance, and the Series B warrants will expire on the two and one half-year anniversary from the date of issuance.

Commercial discussions with prospective customers have advanced along with the shipment of product for customer testing as the Company continues to progress towards Phase 1 commercial operation Commercial discussions with prospective customers have advanced along with the shipment of product for customer testing as the Company continues to progress towards Phase 1 commercial operation

Company will provide an update on the operational strategy and recently announced organizational changes Company will provide an update on the operational strategy and recently announced organizational changes

Additional notes expands the Company's runway for further refinement of active operational process development and expanded commercial arrangements

The facility of 5E Advanced (FEAM) is now operational 24/7 as shift operators have been trained and staffed.